Stay updated on MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.

Latest updates to the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page
- Check2 days agoChange DetectedA notice about NIH website terminology changes appears above the study record, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference0.5%

- Check9 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check16 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check37 days agoChange DetectedA new revision entry v3.7.0 was added to the study history, and the previous v3.6.6 entry was removed. This updates the page's revision history to reflect the latest version of the record.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.6.6 was added to the page history and Revision: v3.6.5 was removed. This reflects an update to the page's revision metadata within the record history.SummaryDifference0.1%

- Check79 days agoChange DetectedThe Study Record History now shows a new revision label v3.6.5 added, and the previous v3.6.4 label removed, indicating the page has been updated to a newer version. This change updates the version metadata without altering the study data.SummaryDifference0.1%

Stay in the know with updates to MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.